Companies
Companies
Alcami Boosts Pharma Storage with Exciting Upgrades!
Alcami expands its NC facility! 📦 New cold storage options 🌡️ enhance support for biopharma. 🚀 Discover the latest services! 🧪🌎
Agilent’s $925M Biovectra Buy: Boosting Growth!
Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦
Breaking News: Gene Therapy Partnership Expands!
📢 Univercells Technologies and UPENN are expanding their partnership to evaluate gene therapy manufacturing scalability. 🧪 The goal is accessibility and cost reduction. 💪🏭👨🔬
Unlocking the Potential of Cell and Gene Therapies: The Game-Changing Solution
🧪 The cell and gene therapy market is growing rapidly, but development and manufacturing are complex. 🌍 SmartLabs offers a solution by hosting drug discovery, development, and manufacturing facilities in one location. 💰 This reduces costs and resources needed for non-scientific services, allowing companies to focus on developing robust processes. 💡 SmartLabs' modular facilities are customizable and phase-compliant, making it easier to transition through the drug development journey. 👥 Clients have access to expertise and support, and they retain control over their manufacturing process and IP. 🔬 SmartLabs aims to accelerate scientific breakthroughs and adapt to the evolving life sciences industry.
CordenPharma’s €900m Investment to Dominate Peptide Market
📢 CordenPharma invests €900m in peptide platform expansion, aiming to become a market leader and reach €1bn in sales by 2028. 🔬💊💪
Catalym Raises $150m for Cancer Breakthrough
💰 German cancer specialist Catalym GmbH raises $150m to fund proof-of-concept studies 🔬💉🧪💼 Exciting progress in solid tumor treatment!
French Company’s Breakthrough Treatment Halts Hearing Loss
📢 Exciting news! Sensorion SA has achieved positive results in their Phase II trial for SENS-401, a treatment for hearing loss. 🦻🔬👂
Rentschler Biopharma Doubles Production Capacity Making History
🏢 Rentschler Biopharma doubles cGMP capacity with new US production line, aiming to expand in complex biologics market. 🌍📈💰
Massachusetts Welcomes Fully Operational Biopharma Powerhouse
📢 Rentschler Biopharma's new production line in Massachusetts is now fully operational. 🏭 The multi-product facility doubles the company's global capacity and focuses on the commercial production of complex molecules. 🔬 The production line includes four new 2,000L single-use bioreactors and adds 22,000 square feet of cleanroom space. 🇺🇸 CEO Benedikt von Braunmühl highlights the company's strong capabilities in the US. 🚀 Rentschler Biopharma contributed to nearly 25 of FDA-approved biopharmaceuticals in 2023.
German Biotech Startup Raises €63m for Groundbreaking Autoimmune Research
🎉 German biotech SciRhom GmbH secures €63m in Series A funding to advance clinical proof of concept in autoimmune disorders. 💪🔬🌍
